3rd International AIDS Society Conference on HIV Pathogenesis and Treatment Rio de Janeiro - July 24 - 27, 2005

HIV/AIDS CARE AND TREATMENT IN UGANDA CASE STUDY OF TASO

IAS Conf HIV Pathog Treat 2005 Jul 24-27;3rd: Abstract No. MoPe11.1C03

Sebuliba I., Coutinho A., Nabiryo C.
The AIDS Support Organisation (TASO), Kampala, Uganda

INTRODUCTION: The first case if AIDS in Uganda was reported in 1982. The current HIV infection of an estimated 1.1 million people who are in the prime of their lives has an adverse impact on the quality of life of the population. AIDS is currently responsible for 12% of total annual deaths in Uganda. The AIDS Support Organisation (TASO) with in its donor given resources develops programs to help the situation in Uganda.

METHODS: Data collected from 1989 to 2004 has been analysed in addition to key informant interviews with Project Officers, ART Coordinators. Using ART in the treatment of HIV/AIDS that reduces HIV/AIDS related mortality and morbidity, prolongs life expectancy, and improves quality of life and productivity of AIDS patients.

RESULTS: 1) TASO has an active clientele of 35000 who receive counselling and medical services for opportunistic infections. 2) It is estimated that about 100,000 people in Uganda are living with AIDS and in need of ARVs. 3) TASO is to give 3000 clients free ARVs the process that started in the year 2004. 4) TASO has set up monitoring and evaluation systems that give feedback regarding the process to start and continuing uptake ARVs in the ART scale-up activities. 5) TASO has field officers, medicine companions, community nurses, and volunteers that monitor clients for all conditions and refer to TASO clinics where needed.

CONCLUSIONS: 1) There is need for more resource mobilization in order to get funds to ensure sustainability and continuity on the ART Program. 2) There is need for sensitisation and formation of rural HIV/AIDS awareness programs. 3) Establish a standard monitoring and evaluation system for ART. 4) Set up conditions that allow local companies to repackage imported ingredients or produce generic ARVs. 5) Creation of mobile clinics targeting families with HIV/AIDS persons.

Download PDF of this abstract.

050724
Clinical | MoPe11.1C03 | Isaac Sebuliba
Access to care

Copyright © 2005 - International AIDS Society (IAS). All information and content relating to the abstracts from the 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.

AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.